The contraception market is made up of many different types of products, from those offering long term reversible contraception (LARCS) to daily combined or progesterone only pills. New and existing brands need to fight for market share and face many challenges around formulary restrictions, cost, HCP familiarity or experience with certain products, competitor advantages plus patient choice. As a result, how do brands engage with multiple NHS stakeholders and their patients to drive usage? What support and/or educational packages are needed alongside brands?
Adelphi also has previous experience in other areas of women’s health, such as, heavy menstrual bleeding (HMB) and In-Vitro Fertilisation (IVF).
Experienced Consultants in Women's Health
Our Therapy Area Team will work closely with you to help identify the most suitable approach, challenge when necessary and provide actionable insights to help navigate your marketing challenges. We have dedicated Senior Consultants and Therapy Area Teams that keep abreast of the full market landscape.
Adelphi MarketMapsTM have been developed to summarise and visualise the full market landscape including the key challengers, market trends and the likely impact of pipeline treatments.
The Types of Challenges we Help to Solve
- Understanding current treatment practices and drivers of choice
- Campaign development and testing, ensuring campaigns reflect reality
- Optimising pricing strategies
- Understanding the patient journey and experiences
- Developing segmented communication strategies
- Understanding physician/patient disconnects